Liver-Healthy baby formula study pulled before it began
NCT ID NCT05922332
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study aimed to see if a milk powder rich in medium chain fatty acids could improve nutrition and disease status in infants with cholestatic liver disease. It planned to enroll babies aged 6 months or younger who were formula-fed and had cholestasis for over a month. The study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTATIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
zhaoyang Gou
Shanghai, China
Conditions
Explore the condition pages connected to this study.